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Abstract: Modern experiments have offered alternative interpretations on the symmetry of chiral
dirhodium(II) carboxylate complexes and its relationship to their level of enantioselectivity. So, this
contribution is to provide an insight on how the knowledge around the structure of these catalysts has
evolved with a particular emphasis on the impact of this knowledge on enantioselectivity prediction
and catalyst design.
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1. Introduction
Chiral dirhodium(II) paddlewheel complexes are among the most attractive catalysts that found
a widespread application in the fields of metal-nitrene and metal-carbene transformations [1–15].
This immense interest originates from their exceptional ability to effectively catalyze a broad spectrum
of reactions with high levels of chemo-, regio- and stereo-selectivity. These transformations involve
aziridinations [16–18], C-H insertions [7,19,20], ylide transformations [21–25], Lewis acid-promoted
reactions [21,26–30], cross-coupling reactions [31], cyclopropanation and cyclopropenation
reactions [32–35]. In fact, they have proven their potential, particularly, in the field of asymmetric
synthesis. As an example to showcase the utility of these complexes, methyl styryldiazoacetate
(1), in the presence of a suitable substrate and a dirhodium(II) catalyst, can undergo a range of
chemical transformations including cyclopropanation [36–38], C-H insertion [39,40], Si-H insertion [41],
tandem cyclopropanation/Cope rearrangement [42,43], tandem O-H insertion/[2,3] sigmatropic
rearrangement [44], vinylogous reactivity [45,46], tandem C-H insertion/Cope rearrangement [47,48],
or [3+2] cycloaddition [49] generating a variety of useful synthetic entities in excellent diastereo- and
enantioselectivity (Scheme 1).
Chiral dirhodium(II) carboxylate complexes constitute a very important class of dirhodium(II)
catalysts. Their structure consists of two rhodium atoms connected together through a unique
dirhodium bridge. This dirhodium axes is connected to four chiral electron withdrawing
carboxylate ligands and they have two vacant axial positions available for carbene binding [50,51].
Although several highly enantioselective dirhodium(II) carboxylate catalysts have been reported to
date [2,52] and their application spectrum has expanded dramatically, limited evidence is known on
how chirality is tailored at the active center of these complexes by its four chiral carboxylate ligands.
As a consequence, this article is providing an insight on how the knowledge around the structure of
dirhodium(II) carboxylate complexes has evolved. This is with a particular emphasis on the impact of
this knowledge on enantioselectivity prediction and catalyst design. To the best of our knowledge,
this topic was last reviewed by Hansen and Davies in 2008 [53] and since then subsequent investigations
have offered alternative interpretations on the symmetry of chiral dirhodium(II) carboxylate complexes
and its relationship to their level of enantioselectivity.
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Scheme 1. Dirhodium(II)-mediated chemistry of methyl styryldiazoacetate (1) with different 
substrates. 
2. Ligand Blocking Groups Arrangements 
Generally for chiral dirhodium(II) carboxylate complexes, it is agreed that the ligand blocking 
groups can adapt either an up (α) or down (β) positions around the catalyst core. It was also assumed 
that, the ligand’s blocking group cannot be situated in the periphery of the dirhodium(II) core as it 
would bump into the neighboring ligand [36,53]. Thus, by taking into account the α- and β-
arrangements for all four ligands, four possible conformations can be mainly considered: α,α,α,α (C4-
symmetry), α,α,β,β (C2-symmetry), α,β,α,β (D2-symmetry) and α,α,α,β (C1-symmetry) (Figure 1) 
[2,4,36,53,54]. 
 
Figure 1. Main arrangements of ligand’s blocking groups around the dirhodium(II) core and their 
point groups (the sterically blocking groups around the rhodium active sites are depicted as ovals) 
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Figure 1. Main arrangements of ligand’s blocking groups around the dirhodium(II) core and
their point groups (the sterically blocking groups around the rhodium active sites are depicted as
ovals) [2,4,36,53,54].
2.1. α,β,α,β-Conformation
Initially, Hansen and Davies suggested that catalysts having two different carbene-formation
sites should not lead to high enantiocontrol [53]. In other words, complexes with α,α,β,β- and
α,β,α,β-arrangements (having C2- and D2-symmetry, respectively) are the only effective catalysts
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in terms of enantioselectivity as they possess two equivalent catalyst faces. While complexes with
α,α,α,α- and α,α,α,β-conformations, which have non-equivalent catalyst faces, are likely to induce low
or no enantioinduction as their more accessible and kinetically active face is achiral. This previous
proposal from Davies et al. originates from their discovery of Rh2(S-DOSP)4 catalyst (Scheme 2) [36],
which offered extraordinary enantioselectivity in a wide range of chemical transformations (up to
99% ee) [7,13,36,40,42,44,47,48,55–68]. This exceptional enantioselectivity of Rh2(S-DOSP)4 was
proposed to originate from a favored α,β,α,β-arrangement of ligands adapted during catalysis.
The arrangement that leads to a catalyst with two equivalent rhodium active sites and adequate
sterically overburden groups that can limit the trajectories approaching the axial carbene ligand
(Scheme 2) [7,13,36,53]. For example, low temperature Rh2(S-DOSP)4-catalyzed cyclopropanation of
styrene with methyl styryldiazoacetate resulted in the generation of the corresponding cyclopropane
product in more than 50:1 E/Z diastereomeric ratio and 98% ee (Scheme 2a) [13,69]. A general model
was then proposed to explain the observed stereochemical outcome [13,36,68,70]. In this model,
Rh2(S-DOSP)4 is assumed to favor the α,β,α,β-conformation during catalysis at which, the si-face of
the metal-carbene complex is protected by a ligand blocking group. The substrate will approach from
the re-face to generate the product in the observed absolute configuration (Scheme 2a).
Catalysts 2017, 7, 347    3 of 19 
 
enantioselectivity as they posse s two equivale t catalyst faces. While complexes w th α,α,α,α‐ and 








example,  low  temperature  Rh2(S‐DOSP)4‐catalyzed  cyclopropanation  of  styrene  with  methyl 
styryldiazoacetate  resulted  in  the generation of  the corresponding cyclopropane product  in more 
than  50:1  E/Z  diastereomeric  ratio  and  98%  ee  (Scheme  2a)  [13,69]. A  general model was  then 
proposed to explain the observed stereochemical outcome [13,36,68,70]. In this model, Rh2(S‐DOSP)4 
is  assumed  to  favor  the α,β,α,β‐conformation during  catalysis  at which,  the  si‐face  of  the metal‐






Scheme 2. Struct re, D2-sym etry and facial enantioselecti it i ti selective cyclopropanation of
styrene with methyl styr ldiazoacetate of Rh2(S-DOSP)4 and Rh2(S-biTISP)2 as proposed by a i et al.
(a) Rh2(S-DOSP)4-catalyzed reaction [13,36,69], (b) Rh2(S-biTISP)2-catalyzed reaction [13,71].
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To support the D2-symmetry hypothesis of Rh2(S-DOSP)4, the authors introduced the second
generation prolinate-based complex, Rh2(S-biTISP)2 (Scheme 2) [13,71,72]. As the ligands themselves
possess a C2-symmetry, Rh2(S-biTISP)2 was anticipated to adapt the higher D2-symmetrical structure.
More importantly, the complex was expected to be more rigid at which, the ligands are conformationally
locked in the α,β,α,β-arrangement around the catalyst active centers. For this catalyst, not only both
faces are equivalent but also all staggered binding orientations of the axial carbene ligands are identical
with respect to the approaching substrate [13,53,71]. As expected by the authors, Rh2(S-biTISP)2
demonstrated excellent enantioselectivity in the enantioselective intermolecular cyclopropanation
of styrene with methyl styryldiazoacetate leading to the generation of the cyclopropane product
in 98% ee (Scheme 2b) [13,71]. This result very well supported the proposed concept that the
observed enantioselectivity of Rh2(S-DOSP)4 originates from an α,β,α,β-conformation adapted during
catalysis. However, the use of Rh2(S-biTISP)2 catalyst preferentially resulted in the generation of
the (1S,2S)-cyclopropane product (Scheme 2b) which was the opposite to that obtained with the
Rh2(S-DOSP)4-catalysed reaction (Scheme 2a). The authors returned this difference in asymmetric
induction to the different preferred staggered orientation for the carbene binding which causes different
channels of the metal-carbene intermediate to be exposed to the approaching alkene [13].
In the same context, Rh2(R-BTPCP)4 was also reported as a catalyst that exhibited high
enantioselectivity levels [73–75]. For example, the Rh2(R-BTPCP)4-catalyzed cyclopropanation of
styrene with methyl styryldiazoacetate generated the cyclopropane product in 92% ee [73]. Based on its
X-ray crystal structure, this enantioselectivity was again returned to the α,β,α,β-distribution of ligands
around the dirhodium(II) core (Scheme 3) [73].
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Scheme 4. Rh2(R-3,5-di(p-tBuPh)TPCP)4-catalysed C-H functionalization of pentane and substituted
n-alkanes and the D2-symmetric structure of the catalyst according to its X-ray crystal structure. The two
3,5-di(p-tBuPh)C6H3-groups are highlighted in yellow. (X-ray crystal structure adapted with permission
from Macmillan Publishers Ltd.: Liao, K.; Negretti, S.; Musaev, D.G.; Bacsa, J.; Davies, H.M.L. Nature
2016, 533, 230–234, Copyright 2017).
2.2. α,α,β,β- and α,α,α,α-Conformations
2.2.1. Global Catalyst Symmetry
The previous proposal that only catalysts with D2- and C2-symmetric structures are effective in
terms of enantiocontrol [53] relied also on Hashimoto’s reports for Rh2(S-PTTL)4. In 1993, Hashimoto,
Ikegami and co-workers first reported their famous complex, Rh2(S-PTTL)4 [76,77], as a catalyst
that manifested (along with its variants) high enantioselectivity levels in wide range of organic
transformations [2,54,78–84]. For example, in enantioselective [2,3]-sigmatropic rearrangement of the
cyclic propargylic oxonium ylide shown in Scheme 5a, Rh2(S-PTTL)4 provided the best enantioselectivity
of 79% ee of the corresponding allenic bearing benzofuran-3-one product (Scheme 5a) [85].
Hashimoto et al. initially proposed that Rh2(S-PTTL)4 favors the α,α,β,β-conformation during
catalysis. This assumption was based on the X-ray crystal structure of its analogue, Rh2(S-PTPA)4, which
also showed moderate to good enantioselectivity in some asymmetric transformations [76,79,85,86].
For example, in aromatic C-H insertion of α-diazoketones, Rh2(S-PTPA)4 resulted into the formation of
the corresponding 1-alkyl-1-phenyl-2-indanones in up to 95% ee (Scheme 5b) [86]. The X-ray crystal
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structure of Rh2(S-PTPA)4 showed that the catalyst is adapting the α,α,β,β-conformation in solid state
(Scheme 5b) [76,85–87].
Based on Hashimoto’s hypothesis, a general model was proposed to account for the observed
enantioselectivity with Rh2(S-PTTL)4 [85,86,88,89]. In this model, it was proposed that Rh2(S-PTTL)4
preferentially adapts the α,α,β,β-conformation during catalysis. The carbene orients itself at which,
its bulky side is directed away from the catalyst walls (Scheme 5a). The substrate approaches from the
re-face to generate the product in the observed absolute configuration.Catalysts 2017, 7, 347    6 of 19 
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Later, Davies et al. noticed that, in some reactions, the steric bulk of the ligand affects the
enantioselectivity of the catalyst at which the enantioselectivity increased by increasing the steric bulk at
the α-carbon of the ligands. For example, in dirhodium(II)-catalyzed enantioselective tandem carbonyl
ylide formation/intermolecular 1,3-dipolar cycloaddition of α-diazoketones, the best enantioselectivity
was observed when Rh2(S-PTTL)4 was used as a catalyst (74% ee), followed by Rh2(S-PTV)4 (51% ee)
and Rh2(S-PTA)4 (35% ee) [90] (Scheme 6a). As a consequence, Davies et al. suggested that the logical
way to further develop the Rh2(S-PTTL)4 catalyst is to substitute the tert-butyl group connected to
the α-carbon with a much bulkier hydrocarbon group. Accordingly, they introduced Rh2(S-PTAD)4
catalyst which is derived from L-adamantylglycine ligands (Scheme 6b) [37]. As expected, this catalyst
succeeded to afford enantioselectivity levels superior to Rh2(S-PTTL)4 in different asymmetric
transformations [37,88,91–95]. For example, Rh2(S-PTAD)4-catalyzed cyclopropanation of styrene with
α-diazobenzylphosphonate resulted into the generation of the corresponding cyclopropylphosphonate
product in high levels of enantioselectivity (99% ee) compared to Rh2(S-DOSP)4 (34% ee), Rh2(S-biTISP)2
(88% ee) and Rh2(S-PTTL)4 (97% ee) (Scheme 6b) [37].
Catalysts 2017, 7, 347    7 of 19 
 
in  different  asymmetric  transformations  [37,88,91–95].  For  example,  Rh2(S‐PTAD)4‐catalyzed 
cyclopropanation  of  styrene with  α‐diazobenzylphosphonate  resulted  into  the  generation  of  the 




Scheme  6.  (a)  Dirhodium(II)‐catalyzed  enantioselective  tandem  carbonyl  ylide 
formation/intermolecular  1,3‐dipolar  cycloaddition  of  α‐diazoketones  [90];  (b)  Rh2(S‐PTAD)4‐
catalyzed enantioselective synthesis of dimethyl 1,2‐diphenylcyclopropylphosphonate [37]. 
Up to this point, Hansen and Davies theoretical assumption that only catalysts with α,α,β,β‐ and 







Scheme 6. (a) Dirhodium(II)-catalyzed enantioselective tandem carbonyl ylide formation/intermolecular
1,3-dipolar cycloaddition of α-diazoketones [90]; (b) Rh2(S-PTAD)4-catalyzed enantioselective synthesis
of dimethyl 1,2-diphenylcyclopropylphosphonate [37].
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Up to this point, Hansen and Davies theoretical assumption that only catalysts with α,α,β,β- and
α,β,α,β-arrangements results in high enantioselectivity and not the others [53] was very well supported
by scientific evidence. Nevertheless in 2009, Fox et al. were able to capture an X-ray crystal structure
for Rh2(S-PTTL)4 [78,87]. Surprisingly, the obtained structure revealed that the catalyst is adapting the
α,α,α,α-conformation in solid state and not the expected α,α,β,β-conformation (Figure 2). Furthermore,
the structure showed that the catalyst is having a rectangular chiral cavity (C2- rather than C4-symmetry)




illustration  of  the  rectangular  binding  pocket  of  Rh2(S‐PTTL)4;  (b)  Space  filling  structure  of 
mono(EtOAc)  adduct  of  Rh2(S‐PTTL)4  (side  view).  (Adapted  from  Adly,  F.G.;  Gardiner,  M.G.; 
Ghanem, A. Chem. Eur. J. 2016, 22, 3447, Copyright 2017, with permission from John Wiley and Sons). 



























PTTL)4  leading  to  the observed more enantioselective outcome. Moreover, Fürstner et al. recently 
succeeded  in  capturing  an  X‐ray  crystal  structure  of  the  Rh2(S‐PTTL)4=C(MeOC6H4)CO2Me 
intermediate (Figure 3) [97]. The obtained structure showed that the entire carbene resides within a 
Figure 2. (a) Space filling structure of o ct of h2(S-P TL)4 (top view); Schematic
illustration of the rectangular binding pocket of Rh2(S-PTTL)4; (b) Space filling structure of mono(EtOAc)
adduct of Rh2(S-PTTL)4 (side view). (Adapted from Adly, F.G.; Gardiner, M.G.; hanem, A. Chem. Eur.
J. 2016, 22, 3447, Copyright 2017, with permission from John Wiley and Sons).
Based on the new information, F t l. introduced a new model to account for the
enantioselectivity exhibited by Rh2(S-PTTL)4 in enantioselective cyclopropanation of styrene with
α-alkyldiazoesters (Scheme 7) [78,87]. In this model, Rh2(S-PTTL)4 was proposed to keep its
α,α,α,α-conformation during catalysis and the carbene is anticipated to align itself within the
wide dimension of the catalyst’s rectangular cavity leaving its si-face accessible by the substrate.
Also according to Fox model, the tert-butyl groups are crucial to restrict the reactivity to the chiral
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Scheme 7. Facial selectivity of the Rh2(S-PTTL)4-stabilized carbene according to the model proposed
by Fox et al. [78,87].
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Fox model was very well supported by the results obtained earlier for Rh2(S-PTAD)4 by being
more enantioselective than Rh2(S-PTTL)4 [37,91–93,95,96]. The results were very relevant as the much
bulkier adamantyl groups would more efficiently block the carbene ligands from coordinating to
the achiral rhodium face (shrouded by the adamantly groups) compared to the tert-butyl groups
of Rh2(S-PTTL)4 leading to the observed more enantioselective outcome. Moreover, Fürstner et al.
recently succeeded in capturing an X-ray crystal structure of the Rh2(S-PTTL)4=C(MeOC6H4)CO2Me
intermediate (Figure 3) [97]. The obtained structure showed that the entire carbene resides within
a long narrow pocket formed by the four N-phthalimido groups of Rh2(S-PTTL)4, that adapt an
α,α,α,α-arrangement (C2-symmetric). The overall situation looked, therefore, in good agreement with
the model proposed by Fox. But, low temperature NMR data for this intermediate returned a single
set of signals for the four chiral carboxylate ligands [97]. This observation was not in a good accord
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Fox proposal was also challenged by data reported from different research groups. Adly, Ghanem
and co-workers reported the X-ray crystal structure of Rh2(S-PTAD)4 [98]. Similar to Rh2(S-PTTL)4,
the obtained structure showed that the catalyst is adapting the α,α,α,α-conformation in solid state,
however, the catalyst was observed to form a bis(EtOAc) adduct when crystalized from ethyl
acetate/n-hexane (Figure 4). This observation contradicted with the assumption proposed by Fox et al.
in their model and confirmed that the adamantyl groups are not completely blocking the “achiral”
catalyst face. In other words, there is still enough room for a Lewis basic ligand to coordinate to the
achiral axial rhodium site. This observation provided direct evidence that both Rh atoms are still
accessible by the diazo substrates even after the introduction of the bulkier adamantyl groups [98].
In addition, results have shown that complexes with tert-butyl groups at their α-carbon produced
enantioselectivity levels similar and sometimes higher than Rh2(S-PTAD)4 which carries the bulkier
adamantyl groups [98].
Also, different reported observations confirmed the flexibility of the PTTL ligands around the
rhodium active center, especially in solution and emphasized the effect of the shape and size of
the axial ligand on the overall structure of the dirhodium(II)-carbene intermediate. For example,
2D heteronuclear NOESY data reported by the groups of Charette [54] and Duddeck [99],
independently, confirmed that Rh2(S-PTTL)4 and analogues have a mobile conformation in solution.
This confirms the existence of other conformers with at least one N-phthalimido group is flipped
downward. Further and based on X-ray crystallographic data, Rh2(S-PTTL)4(NC-C6H4-CN) adduct
was found to adapt a conformation in which one of the ligands is twisted by only about 80◦
in solid state [87]. In other words, the ligand’s blocking group lies in the periphery of the
catalyst, the case that was originally supposed to be problematic due to steric constraints [36,53].
Gardiner and Ghanem [2,100] also succeeded to grow crystals of Rh2(S-PTPA)4(EtOAc)2 and
Rh2(S-PTPA)4(MeOH)(H2O) and they found that different conformations exist for each of these adducts
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at which, all of them feature inequivalent axial coordination sites unlike its original α,α,β,β-structure
previously reported by Hashimoto [76,85–87]. The Rh2(S-PTPA)4(EtOAc)2 adduct exhibited an
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Figure 4. Space filling structure of bis(EtOAc) adduct of Rh2(S-PTAD)4 viewed along the Rh-Rh axis
(a) into the chiral crown cavity, (b) onto the achiral Rh coordination site shrouded by the adamantyl
groups. (c) Side view of bis(EtOAc) adduct of Rh2(S-PTAD)4. (Adapted from Adly, F.G.; Gardiner, M.G.;
Ghanem, A. Chem. Eur. J. 2016, 22, 3447, Copyright 2017, with permission from John Wiley and Sons).
2.2.2. Local Ligand Symmetry
Followin the classical way of catalyst design, all reported chiral dirhodium(II) carboxylate
complexes derived from L-amino acid ligands were designed to have a symmetric N-protecting groups
for the construction of the chiral ligands [4,53]. However in 2004, Müller and Ghanem reported several
Rh2(S-NTTL)4 analogues at which, one hydrogen on the N-protecting group is substituted to generate
catalysts carrying asymmetric N-protecting groups for asymmetric cyclopropanation of styrene with
dimethyl malonate [101] and Meldrum’s acid [102] (Scheme 8). The authors were surprised when
screening results revealed that Rh2(S-4-Br-NTTL)4-catalyzed cyclopropanation proceeded with far
improved levels of enantioselectivity compared to Rh2(S-NTTL)4.
Unfortunately, the authors had no success in growing X-ray quality crystals for Rh2(S-4-Br-NTTL)4.
Instead, the X-ray crystal structure of Rh2(S-NTTL)4 (Figure 5) was used as a model to account for
the enhanced enantioselectivity that accompanied Rh2(S-4-Br-NTTL)4 [102]. The authors proposed
that, if Rh2(S-4-Br-NTTL)4 is retaining a similar structure to Rh2(S-NTTL)4 during catalysis (following
Fox et al. proposal), the bromo-substituents would be situated at the cavity rim and are likely to
exert a strong influence on the enantiofacial discrimination of the approaching substrate leading to
the observed enhanced enantioselectivity. The authors also returned the improved performance of
the 4-Br substituted catalyst over the 4-Cl analogue to the size of the substituents. The larger bromo-
substituents are expected to exert more influence at the cavity rim leading to higher enantioselectivity
in the case of Rh2(S-4-Br-NTTL)4.
Later, Adly and Ghanem investigated this further and t ey introduced a new approach for
the design of dirhodium(II) carboxylate complexes. This approach is through the reduction of
the N-protecting group symmetry by the inclusion of a bulky substituent at the catalyst’s cavity
rim. By the application of their new approach, the authors were able to introduce their catalyst,
Rh2(S-tertPTTL)4 (Scheme 9) [89,98,103]. For this catalyst, the planarity of the N-phthalimido groups
is maintained but the local symmetry of the N-protecting group was reduced from C2v to Cs by
virtue of the substituents. Screening of Rh2(S-tertPTTL)4 in different enantioselective cyclopropanation
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reactions demonstrated that, generally, Rh2(S-tertPTTL)4 is more enantioselective than Rh2(S-PTTL)4,










Following  the  classical way  of  catalyst design,  all  reported  chiral dirhodium(II)  carboxylate 
complexes derived  from  L‐amino  acid  ligands were designed  to  have  a  symmetric N‐protecting 
groups  for  the  construction  of  the  chiral  ligands  [4,53]. However  in  2004, Müller  and Ghanem 
reported  several Rh2(S‐NTTL)4  analogues  at which,  one  hydrogen  on  the N‐protecting  group  is 
substituted  to  generate  catalysts  carrying  asymmetric  N‐protecting  groups  for  asymmetric 
cyclopropanation of styrene with dimethyl malonate [101] and Meldrum’s acid [102] (Scheme 8). The 
authors  were  surprised  when  screening  results  revealed  that  Rh2(S‐4‐Br‐NTTL)4‐catalyzed 


















X = Cl, Rh2(S-4-Cl-NTTL)4
X = Br, Rh2(S-4-Br-NTTL)4







4Å MS, Rh catalyst, rt
DCM, PHI=O, Al2O3,
















Scheme 8. Dirhodium(II)-catalyzed enantioselective cyclopropanation of styrene with dimethyl
malonate [101] and Meldrum’s acid [102].
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that,  generally,  Rh2(S‐tertPTTL)4  is  more  enantioselective  than  Rh2(S‐PTTL)4,  while  returning 
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Figure 5. Space filling structure of bis(EtOAc) adduct of Rh2(S-NTTL)4 (top and side view). (Reprinted
from Ghanem, A.; Gardiner, M.G.; Williamson, R.M.; Müller, P. Chem. Eur. J. 2010, 16, 3291, Copyright
2017, with permission from John Wiley and Sons).
The X-ray crystal structure of Rh2(S-tertPTTL)4 showed that the catalyst is adapting the
α,α,α,α-conformation in solid state (Scheme 9) featuring the tert-butyl substituents similarly disposed
towards the “corner” of the nearly square-shaped cavity. The cavity is approximately square if
compared to the reported structure of Rh2(S-PTTL)4. The authors claimed that the added tert-butyl
substituent on the N-phthalimido group in Rh2(S-tertPTTL)4 reinforced the overall chiral twist of the
cavity, while, at the same time, not placing added steric hindrance to the binding of axial carbene
ligand [98]. The authors proposed that, if this geometry is relevant during catalysis, it is likely to be
the reason for the observed enhanced enantioselectivity relative to its parent, Rh2(S-PTTL)4.






Scheme 9. Rh2(S-tertPTTL)4-catalyzed enantioselective synthesis of dimethyl 1,2-
diphenylcyclopropylphosphonate and X-ray crystal structure of Rh2(S-tertPTTL)4 (top view).
(X-ray crystal structure adapted from Adly, F.G.; Gardiner, M.G.; Ghanem, A. Chem. Eur. J. 2016, 22,
3447, Copyright 2017, with permission from John Wiley and Sons).
2.3. α,α,α,β-Conformation
In 2012, Charette et al. explored the replacement of one of the ligands of Rh2(S-TCPTTL)4
(the chlorinated version of Rh2(S-PTTL)4) with N-phthalimido-2-aminoisobutyric acid ligand (PTAiB).
This led to the generation of the lower symmetry heteroleptic complex, Rh2(S-TCPTTL)3(PTAiB) [104].
The X-ray crystal structure of this complex revealed that it is adapting the α,α,α,β-conformation in solid
state (Scheme 10). Surprisingly, screening results demonstrated that lowering the global symmetry
of the catalyst had a beneficial impact on its enantioselectivity. In the cyclopropanation reaction of
alkenes with α-nitro diazoacetophenones, Rh2(S-TCPTTL)3(PTAiB) resulted into the formation of the
cyclopropane product in 96.4% ee which was higher compared to its parent Rh2(S-TCPTTL)4 (92.4% ee)
(Scheme 10).
Also in the same year, Fox et al. reported the mixed ligated complex, Rh2(S-PTTL)3(TPA)
(Scheme 11) [105]. The X-ray crystal structure of this complex showed that all of the N-phthalimido
groups are on one face of the complex in a structural similarity to Rh2(S-PTTL)4 but with an
incomplete chiral pocket (analogous to an α,α,α,β-arrangement). Rh2(S-PTTL)3(TPA) returned its
best enantioselectivity in the cyclopropanation of styrene with ethyl α-diazobutanoate (88% ee)
which was higher than the observed enantioselectivity with Rh2(S-PTTL)4 in the same reaction
(79% ee) (Scheme 11). The scope of this catalyst was expanded to include other substrate classes,
namely aliphatic alkynes, silylacetylenes and α-olefins, that were particularly challenging in
intermolecular cyclopropanations with α-alkyl-α-diazoesters. Generally, Rh2(S-PTTL)3(TPA) was able
to catalyze enantioselective cyclopropanations returning yields and enantioselectivities comparable
and sometimes higher than Rh2(S-PTTL)4 [105].
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undergoing the reaction. Then enantioselection mechanisms can mainly originate from the different 
Sche e 11. Enantioselective cyclopropanation of styrene with ethyl α-diazobutanoate and structure of
Rh2(S-PTTL)3(TPA) according to its X-ray crystal structure [105].
3. Conclusions
From the above demonstration, all models proposed to account for the enantioselectivity observed
with different dirhodium(II) carboxylate catalysts relied mainly on the obtained X-ray crystal structures
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of these catalysts (except for Rh2(S-DOSP)4 and related prolinate-based complexes). However, due to
crystal packing, pi-stacking and/or existence of axial and lattice solvent molecules within the crystal
unit cell, the static pose of a catalyst and its chiral ligands portrayed in its X-ray crystal structure does
not validate the adaption of the catalyst to the same conformation in solution and during catalysis.
In other words, based on the size and the shape of the axial carbene ligand, as well as the reaction
solvent used, the metal-carbene intermediate may adapt a different conformation during catalysis to
the one observed in its X-ray crystal structure.
In fact, carboxylate ligands contain conformationally mobile units [13,54,87,98,99] which might
give the ability to the dirhodium(II) catalyst to adapt its conformation to the particular substrate
undergoing the reaction. Then enantioselection mechanisms can mainly originate from the different
preferred reaction channels as a function of the different steric interactions taking place between
the approaching substrate and the formed dirhodium(II)-carbene complex. This can explain
the compatibility of a particular dirhodium(II) carboxylate catalyst with a particular substrate
returning high levels of enantioselectivity, while the same catalyst might not retain the same level
of enantioselectivity after switching to a different substrate. As a result, catalyst optimization is
always necessary in method development to find the optimum catalyst that can return the highest
possible level of enantioselectivity with the particular substrate undergoing the reaction. Based on
that, researchers must not only limit their focus on the four main conformations of dirhodium(II)
carboxylate complexes and an expansion in the considered conformational space is essential.
Even by relying on the catalyst X-ray crystal structures alone to justify the observed
enantioselectivity, it is obvious from the demonstration above that dirhodium(II) carboxylate catalysts
with α,α,α,α-, α,α,α,β-, α,α,β,β- and α,β,α,β-ligand arrangements were all reported to lead to high
levels of enantioselectivity. As a consequence, the original proposal that catalysts with α,α,β,β- and
α,β,α,β-geometries will only result in high enantioselectivity [53] can no longer be considered as valid.
In other words, symmetry of the catalyst is not a mandatory prerequisite for achieving high levels of
enantioselectivity. Subsequently, the use of high symmetry ligands as the traditional way to produce
high symmetry catalysts [53] may not be as essential as previously thought.
All in all, although the knowledge around the structure of dirhodium(II) carboxylate complexes
has been expanded dramatically in the last decade, the topic is still in its infancy. With the fast
development in X-ray crystallography, computational chemistry and NMR spectroscopy, researchers
may prosper in solving the mystery behind this topic. This, in turn, will aid to a great extent in the
design of highly stereoselective chiral dirhodium(II) catalysts in the future.
Acknowledgments: The author would like to acknowledge the Chirality research group members at the University
of Canberra, Australia, for their support.
Conflicts of Interest: The author declares no conflict of interest.
References
1. Davies, H.M.L.; Manning, J.R. Catalytic C-H functionalization by metal carbenoid and nitrenoid insertion.
Nature 2008, 451, 417–424. [CrossRef] [PubMed]
2. Adly, F.G.; Ghanem, A. Enantiomerically Pure Compounds by Enantioselective Synthetic Chiral Metal
Complexes. In Asymmetric Synthesis of Drugs and Natural Products; Nag, A., Ed.; CRC Press: Raton, FL, USA,
2018; in press.
3. Deng, Y.; Qiu, H.; Srinivas, H.D.; Doyle, M.P. Chiral Dirhodium(II) Catalysts for Selective Metal Carbene
Reactions. Curr. Org. Chem. 2016, 20, 61–81. [CrossRef]
4. Adly, F.G.; Ghanem, A. Chiral Dirhodium (II) Carboxylates and Carboxamidates as Effective Chemzymes in
Asymmetric Synthesis of Three-Membered Carbocycles. Chirality 2014, 26, 692–711. [CrossRef] [PubMed]
5. El-Deftar, M.; Adly, F.G.; Gardiner, M.G.; Ghanem, A. Chiral Dirhodium Catalysts: A New Era for
Asymmetric Catalysis. Curr. Org. Chem. 2012, 16, 1808–1836. [CrossRef]
6. Trindade, A.F.; Coelho, J.A.S.; Afonso, C.A.M.; Veiros, L.F.; Gois, P.M.P. Fine Tuning of Dirhodium(II):
Expolring the Axial Modification. ACS Catal. 2012, 2, 370–383. [CrossRef]
Catalysts 2017, 7, 347 15 of 19
7. Davies, H.M.L.; Morton, D. Guiding principles for site selective and stereoselective intermolecular C-H
functionalization by donor/acceptor rhodium carbenes. Chem. Soc. Rev. 2011, 40, 1857–1869. [CrossRef]
[PubMed]
8. Davies, H.M.L.; Bois, J.D.; Yu, J.-Q. C-H Functionalization in organic synthesis. Chem. Soc. Rev. 2011, 40,
1855–1856. [CrossRef] [PubMed]
9. Doyle, M.P.; Duffy, R.; Ratnikov, M.; Zhou, L. Catalytic Carbene Insertion into C-H Bonds. Chem. Rev. 2010,
110, 704–724. [CrossRef] [PubMed]
10. Davies, H.M.L.; Hedley, S.J. Intermolecular reactions of electron-rich heterocycles with copper and rhodium
carbenoids. Chem. Soc. Rev. 2007, 36, 1109–1119. [CrossRef] [PubMed]
11. Merlic, C.A.; Zechman, A.L. Selectivity in Rhodium(II) Catalyzed Reactions of Diazo Compounds: Effects
of Catalyst ElectoPhilicity, Diazo Substitution and Substrate Substitution. From Chemoselectivity to
Enantioselectivity. Synthesis 2003, 34, 1137–1156. [CrossRef]
12. Colacot, T.J. An overview on the application of “Doyle catalysts” in asymmetric cyclopropanation,
cyclopropenation and C-H insertion reactions. Proc. Ind. Acad. Sci. (J. Chem. Sci.) 2000, 11, 197–207.
[CrossRef]
13. Davies, H.M.L. Dirhodium tetra(N-arylsulfonylprolinates) as chiral catalysts for asymmetric transformations
of vinyl and aryldiazoacetates. Eur. J. Org. Chem. 1999, 30, 2459–2469. [CrossRef]
14. Davies, H.M.L. Rhodium-stabilized vinylcarbenoid intermediates in organic synthesis. Curr. Org. Chem.
1998, 2, 463–488.
15. Collet, F.; Lescot, C.; Liang, C.; Dauban, P. Studies in catalytic C-H amination involving nitrene C-H insertion.
Dalton Trans. 2010, 39, 10401–10413. [CrossRef] [PubMed]
16. Zhang, X.-J.; Yan, M.; Huang, D. Catalyzed addition of diazoacetoacetates to imines: Synthesis of highly
functionalized aziridines. Org. Biomol. Chem. 2009, 7, 187–192. [CrossRef] [PubMed]
17. Yamawaki, M.; Tanaka, M.; Abe, T.; Anada, M.; Hashimoto, S. Catalytic enantioselective aziridination of
alkenes using chiral dirhodium(II) carboxylates. Heterocycles 2007, 72, 709–721. [CrossRef]
18. Catino, A.J.; Nichols, J.M.; Forslund, R.E.; Doyle, M.P. Efficient Aziridination of Olefins Catalyzed by
Mixed-Valent Dirhodium(II,III) Caprolactamate. Org. Lett. 2005, 7, 2787–2790. [CrossRef] [PubMed]
19. Davies, H.M.L.; Denton, J.R. Application of donor/acceptor-carbenoids to the synthesis of natural products.
Chem. Soc. Rev. 2009, 38, 3061–3071. [CrossRef] [PubMed]
20. Kubiak, R.W.; Mighion, J.D.; Wilkerson-Hill, S.M.; Alford, J.S.; Yoshidomi, T.; Davies, H.M. Enantioselective
Intermolecular C-H Functionalization of Allylic and Benzylic sp3 C-H Bonds Using N-Sulfonyl-1, 2,
3-triazoles. Org. Lett. 2016, 18, 3118–3121. [CrossRef] [PubMed]
21. Doyle, M.P. Perspective on Dirhodium Carboxamidates as Catalysts. J. Org. Chem. 2006, 71, 9253–9260.
[CrossRef] [PubMed]
22. Doyle, M.P.; McKervey, M.A.; Ye, T. Modern Catalytic Methods for Organic Synthesis with Diazo Compounds:
From Cyclopropanes to Ylides; Wiley: New York, NY, USA, 1998.
23. Hodgson, D.M.; Stupple, P.A.; Pierard, F.Y.T.M.; Labande, A.H.; Johnstone, C. Development of
dirhodium(II)-catalyzed generation and enantioselective 1,3-dipolar cycloaddition of carbonyl ylides.
Chem.-Eur. J. 2001, 7, 4465–4476. [CrossRef]
24. Doyle, M.P.; Forbes, D.C.; Vasbinder, M.M.; Peterson, C.S. Enantiocontrol in the Generation and
Diastereoselective Reactions of Catalytically Generated Oxonium and Iodonium Ylides. Metal-Stabilized
Ylides as Reaction Intermediates. J. Am. Chem. Soc. 1998, 120, 7653–7654. [CrossRef]
25. Doyle, M.P.; Hu, W. Macrocycle formation from catalytic metal carbene transformations. Synlett 2001, 2001,
1364–1370. [CrossRef]
26. Doyle, M.P.; Phillips, I.M.; Hu, W. A New Class of Chiral Lewis Acid Catalysts for Highly Enantioselective
Hetero-Diels-Alder Reactions: Exceptionally High Turnover Numbers from Dirhodium(II) Carboxamidates.
J. Am. Chem. Soc. 2001, 123, 5366–5367. [CrossRef] [PubMed]
27. Doyle, M.P.; Valenzuela, M.; Huang, P. Asymmetric hetero-Diels-Alder reaction catalyzed by dirhodium(II)
carboxamidates. Proc. Natl. Acad. Sci. USA 2004, 101, 5391–5395. [CrossRef] [PubMed]
28. Wang, Y.; Wolf, J.; Zavalij, P.; Doyle, M.P. Cationic chiral dirhodium carboxamidates are activated for lewis
acid catalysis. Angew. Chem. Int. Ed. 2008, 47, 1439–1442. [CrossRef] [PubMed]
29. Watanabe, N.; Shimada, N.; Anada, M.; Hashimoto, S. Enantio- and diastereoselective hetero-Diels-Alder
reactions between 4-methyl-substituted Rawal’s diene and aldhydes catalyzed by chiral dirhodium(II)
Catalysts 2017, 7, 347 16 of 19
carboxamidates: Catalytic asymmetric synthesis of (−)-cis-aerrangis lactone. Tetrahedron Asymmetry 2014, 25,
63–73. [CrossRef]
30. Anada, M.; Washio, T.; Shimada, N.; Kitagaki, S.; Nakajima, M.; Shiro, M.; Hashimoto, S. A new dirhodium(II)
carboxamidate complex as a chiral Lewis acid catalyst for enantioselective heteo-Diels-Alder reactions.
Angew. Chem. Int. Ed. 2004, 43, 2665–2668. [CrossRef]
31. Hansen, J.H.; Parr, B.T.; Pelphrey, P.; Jin, Q.; Autschbach, J.; Davies, H.M.L. Rhodium(II)-Catalyzed
Cross-Coupling of Diazo Compounds. Angew. Chem., Int. Ed. 2011, 50, 2544–2548. [CrossRef] [PubMed]
32. Doyle, M.P.; Protopopova, M.N. New aspects of catalytic asymmetric cyclopropanation. Tetrahedron 1998, 54,
7919–7946. [CrossRef]
33. Davies, H.M.L.; Antoulinakis, E.G. Intermolecular Metal-Catalyzed Carbenoid Cyclopropanations.
In Organic Reactions; John Wiley & Sons Inc.: Hoboken, NJ, USA, 2001; Volume 57, pp. 1–326.
34. Lebel, H.; Marcoux, J.-F.; Molinaro, C.; Charette, A.B. Stereoselective Cyclopropanation Reactions. Chem. Rev.
2003, 103, 977–1050. [CrossRef] [PubMed]
35. Tsuji, J. Modern Rhodium-Catalyzed Organic Reactions; Wiley-VCH: Weinheim, Germany, 2005.
36. Davies, H.M.L.; Bruzinski, P.R.; Lake, D.H.; Kong, N.; Fall, M.J. Asymmetric Cyclopropanations by
Rhodium(II) N-(Arylsulfonyl)prolinate-Catalyzed Decomposition of Vinyldiazomethanes in the presence of
Alkenes. Practical Enantioselective Synthesis of the four Stereoisomers of 2-Phenylcyclopropan-1-amino
Acid. J. Am. Chem. Soc. 1996, 118, 6897–6907. [CrossRef]
37. Reddy, R.P.; Lee, G.H.; Davies, H.M.L. Dirhodium Tetracarboxylate Derived from Adamantylglycine as
Chiral Catalyst for Carbenoid Reactions. Org. Lett. 2006, 8, 3437–3440. [CrossRef] [PubMed]
38. Davies, H.M.L.; Venkataramani, C. Dirhodium Tetraprolinate-Catalyzed Asymmetric Cyclopropanations
with High Turnover Numbers. Org. Lett. 2003, 5, 1403–1406. [CrossRef] [PubMed]
39. Davies, H.M.L.; Beckwith, E.J. Catalytic enantioselective C-H activation by means of
metal-carbenoid-induced C-H insertion. Chem. Rev. 2003, 103, 2861–2903. [CrossRef] [PubMed]
40. Davies, H.M.; Hansen, T. Asymmetric Intermolecular Carbenoid C−H Insertions Catalyzed by Rhodium
(II)(S)-N-(p-Dodecylphenyl) sulfonylprolinate. J. Am. Chem. Soc. 1997, 119, 9075–9076. [CrossRef]
41. Davies, H.M.; Hansen, T.; Rutberg, J.; Bruzinski, P.R. Rhodium(II)(S)-N-(arylsulfonyl) prolinate catalyzed
asymmetric insertions of vinyl-and phenylcarbenoids into the Si-H bond. Tetrahedron Lett. 1997, 38, 1741–1744.
[CrossRef]
42. Davies, H.M.; Stafford, D.G.; Doan, B.D.; Houser, J.H. Tandem asymmetric cyclopropanation/cope
rearrangement. A highly diastereoselective and enantioselective method for the construction of
1,4-cycloheptadienes. J. Am. Chem. Soc. 1998, 120, 3326–3331. [CrossRef]
43. Davies, H.M.L. [3 + 4] annulations between Rhodium-stabilized vinylcarbenoids and dienes. In Advances in
Cycloaddition, Volume 5; Harmata, M., Ed.; JAI Press INC: Stamford, CT, USA, 1999.
44. Li, Z.; Davies, H.M. Enantioselective C-C Bond Formation by Rhodium-Catalyzed Tandem Ylide
Formation/[2,3]-Sigmatropic Rearrangement between Donor/Acceptor Carbenoids and Allylic Alcohols.
J. Am. Chem. Soc. 2009, 132, 396–401. [CrossRef] [PubMed]
45. Yue, Y.; Wang, Y.; Hu, W. Regioselectivity in Lewis acids catalyzed X–H (O, S, N) insertions of methyl
styryldiazoacetate with benzyl alcohol, benzyl thiol and aniline. Tetrahedron Lett. 2007, 48, 3975–3977.
[CrossRef]
46. Hansen, J.H.; Davies, H.M. Vinylogous reactivity of silver(I) vinylcarbenoids. Chem. Sci. 2011, 2, 457–461.
[CrossRef]
47. Hansen, J.H.; Gregg, T.M.; Ovalles, S.R.; Lian, Y.; Autschbach, J.; Davies, H.M. On the mechanism and
selectivity of the combined C-H activation/Cope rearrangement. J. Am. Chem. Soc. 2011, 133, 5076–5085.
[CrossRef] [PubMed]
48. Davies, H.M.; Jin, Q. Highly Diastereoselective and Enantioselective C-H Functionalization of 1,
2-Dihydronaphthalenes: A Combined C-H Activation/Cope Rearrangement Followed by a Retro-Cope
Rearrangement. J. Am. Chem. Soc. 2004, 126, 10862–10863. [CrossRef] [PubMed]
49. Davies, H.M.; Hu, B. Ring expansion of tert-butyl 1-vinylcyclopropane-1-carboxylates to
alpha-ethylidenebutyrolactones. J. Org. Chem. 1992, 57, 4309–4312. [CrossRef]
50. Pirrung, M.C.; Liu, H.; Morehead, A.T. Rhodium Chemzymes: Michaelis-Menten Kinetics in dirhodium(II)
carboxylate-catalyzed carbenoid reactions. J. Am. Chem. Soc. 2002, 124, 1014–1023. [CrossRef] [PubMed]
Catalysts 2017, 7, 347 17 of 19
51. Nakamura, E.; Yoshikai, N.; Yamanaka, M. Mechanism of C-H Bond Activation/C-C Bond Formation
Reaction between Diazo Compound and Alkane Catalyzed by Dirhodium Tetracarboxylate. J. Am. Chem. Soc.
2002, 124, 7181–7192. [CrossRef] [PubMed]
52. Liao, K.; Negretti, S.; Musaev, D.G.; Bacsa, J.; Davies, H.M.L. Site-selective and stereoselective
functionalization of inactivated C-H bonds. Nature 2016, 533, 230–234. [CrossRef] [PubMed]
53. Hansen, J.; Davies, H.M.L. High Symmetry Dirhodium(II) Paddlewheel Complexes as Chiral Catalysts.
Coord. Chem. Rev. 2008, 252, 545–555. [CrossRef] [PubMed]
54. Lindsay, V.N.G.; Lin, W.; Charette, A.B. Experimental Evidence for the All-Up Reactive Conformation of
Chiral Rhodium(II) Carboxylate Catalysts: Enantioselective Synthesis of cis-Cyclopropane α-Amino Acids.
J. Am. Chem. Soc. 2009, 131, 16383–16385. [CrossRef] [PubMed]
55. Davies, H.M.L.; Bruzinski, P.R.; Fall, M.J. Effect of diazoalkane structure on the stereoselectivity of rhodium(II)
(S)-N-(arylsulfonyl)Prolinate catalyzed cyclopropanations. Tetrahedron Lett. 1996, 37, 4133–4136. [CrossRef]
56. Deng, L.; Giessert, A.J.; Gerlitz, O.O.; Dai, X.; Diver, S.T.; Davies, H.M. Metal carbene-promoted sequential
transformations for the enantioselective synthesis of highly functionalized cycloheptadienes. J. Am. Chem. Soc.
2005, 127, 1342–1343. [CrossRef] [PubMed]
57. Lian, Y.; Davies, H.M. Rhodium-catalyzed [3 + 2] annulation of indoles. J. Am. Chem. Soc. 2009, 132, 440–441.
[CrossRef] [PubMed]
58. Briones, J.F.; Hansen, J.; Hardcastle, K.I.; Autschbach, J.; Davies, H.M.L. Highly enantioselective
Rh2(S-DOSP)4-catalyzed cyclopropenation of alkynes with styryldiazoacetates. J. Am. Chem. Soc. 2010, 132,
17211–17215. [CrossRef] [PubMed]
59. Parr, B.T.; Green, S.A.; Davies, H.M. Rhodium-catalyzed conversion of furans to highly functionalized
pyrroles. J. Am. Chem. Soc. 2013, 135, 4716–4718. [CrossRef] [PubMed]
60. Davies, H.M.; Hansen, T.; Churchill, M.R. Catalytic asymmetric C-H activation of alkanes and
tetrahydrofuran. J. Am. Chem. Soc. 2000, 122, 3063–3070. [CrossRef]
61. Davies, H.M.; Ren, P. Catalytic Asymmetric C-H Activation of Silyl Enol Ethers as an Equivalent of an
Asymmetric Michael Reaction. J. Am. Chem. Soc. 2001, 123, 2070–2071. [CrossRef] [PubMed]
62. Davies, H.M.; Venkataramani, C. Catalytic Enantioselective Synthesis of β2-Amino Acids. Angew. Chem.
Int. Ed. 2002, 41, 2197–2199. [CrossRef]
63. Davies, H.M.; Walji, A.M. Direct Synthesis of (+)-Erogorgiaene through a Kinetic Enantiodifferentiating Step.
Angew. Chem. Int. Ed. 2005, 44, 1733–1735. [CrossRef] [PubMed]
64. Davies, H.M.L.; Manning, J.R. C-H Activation as a Strategic Reaction: Enantioselective Synthesis of
4-Substituted Indoles. J. Am. Chem. Soc. 2006, 128, 1060–1061. [CrossRef] [PubMed]
65. Davies, H.M.L.; Dai, X.; Long, M.S. Combined C-H Activation/Cope Rearrangement as a Strategic Reaction
in Organic Synthesis: Total Synthesis of (−)-Colombiasin A and (−)-Elisapterosin B. J. Am. Chem. Soc. 2006,
128, 2485–2490. [CrossRef] [PubMed]
66. Davies, H.M.L.; Lee, G.H. Dirhodium(II) Tetra(N-(dodecylbenzenesulfonyl)prolinate) Catalyzed
Enantioselective Cyclopropenation of Alkynes. Org. Lett. 2004, 6, 1233–1236. [CrossRef] [PubMed]
67. Lian, Y.; Davies, H.M. Combined C-H functionalization/Cope rearrangement with vinyl ethers as a surrogate
for the vinylogous Mukaiyama aldol reaction. J. Am. Chem. Soc. 2011, 133, 11940–11943. [CrossRef] [PubMed]
68. Davies, H.M.L.; Townsend, R.J. Catalytic asymmetric cyclopropanation of hetereoaryldiazoacetates.
J. Org. Chem. 2001, 66, 6595–6603. [CrossRef] [PubMed]
69. Davies, H.M.; Hutcheson, D.K. Enantioselective synthesis of vinylcyclopropanes by rhodium(II)-catalyzed
decomposition of vinyldiazomethanes in the presence of alkenes. Tetrahedron Lett. 1993, 34, 7243–7246.
[CrossRef]
70. Davies, H.M.L.; Nagashima, T.; Klino, J.L. Stereoselectivity of Methyl Aryldiazoacetate cyclopropanations of
1,1-diarylethylene. Asymmetric synthesis of cyclopropyl analouge of Tamoxifen. Org. Lett. 2000, 2, 823–826.
[CrossRef] [PubMed]
71. Davies, H.M.L.; Panaro, S.A. Novel dirhodium tetraprolinate catalysts containing bridging prolinate ligands
for asymmetric carbenoid reactions. Tetrahedron Lett. 1999, 40, 5287–5290. [CrossRef]
72. Davies, H.M.L.; Kong, N. Synthesis and evaluation of a novel dirhodium tetraprolinate catalyst containing
bridging prolinate ligands. Tetrahedron Lett. 1997, 38, 4203–4206. [CrossRef]
Catalysts 2017, 7, 347 18 of 19
73. Qin, C.; Boyarskikh, V.; Hansen, J.H.; Hardcastle, K.I.; Musaev, D.G.; Davies, H.M.L. D2-Symmetric
Dirhodium Catalyst Derived from a 1,2,2-triarylcyclopropanecarboxylate ligand: Design, Synthesis and
Application. J. Am. Chem. Soc. 2011, 133, 19198–19204. [CrossRef] [PubMed]
74. Qin, C.; Davies, H.M.L. Enantioselective synthesis of 2-arylbicyclo[1.1.0]butane carboxylates. Org. Lett. 2013,
15, 310–313. [CrossRef] [PubMed]
75. Qin, C.; Davies, H.M.L. Rh2(R-TPCP)4-catalyzed Enantioselective [3 + 2]-cycloaddition between nitrones
and vinyldiazoacetates. J. Am. Chem. Soc. 2013, 135, 14516–14519. [CrossRef] [PubMed]
76. Hashimoto, S.; Watanabe, N.; Sato, T.; Shiro, M.; Ikegami, S. Enhancement of Enantioselectivity in
Intramolecular C-H Insertion Reactions of α-Diazo-β-Keto Esters Catalyzed by Chiral Dirhodium(II)
Carboxylates. Tetrahedron Lett. 1993, 34, 5109–5112. [CrossRef]
77. Tsutsui, H.; Abe, T.; Nakamura, S.; Anada, M.; Hashimoto, S. Practical Synthesis of Dirhodium(II)
Tetrakis[N-phthaloyl-(S)-tert-leucinate]. Chem. Pharm. Bull. 2005, 53, 1366–1368. [CrossRef] [PubMed]
78. DeAngelis, A.; Dmitrenko, O.; Yap, G.P.A.; Fox, J.M. Chiral Crown Conformation of Rh2(PTTL)4:
Enantioselective Cyclopropanation with α-Alkyl-α-diazoesters. J. Am. Chem. Soc. 2009, 131, 7230–7231.
[CrossRef] [PubMed]
79. Minami, K.; Saito, H.; Tsutsui, H.; Nambu, H.; Anada, M.; Hashimoto, S. Highly Enantio- and
Diastereoselective Construction of 1,2-Disubstituted Cyclopentane Compounds by Dirhodium(II) Tetrakis[N-
phthaloyl-(S)-tert-leucinate]-Catalyzed C-H Insertion Reactions of α-Diazo Esters. Adv. Synth. Catal. 2005,
347, 1483–1487. [CrossRef]
80. Awata, A.; Arai, T. Catalytic Asymmetric Cyclopropanation with Diazooxindole. Synlett 2013, 24, 29–32.
81. Lindsay, V.N.G.; Nicolas, C.; Charette, A.B. Asymmetric Rh(II)-Catalyzed Cyclopropanation of Alkenes with
Diacceptor Diazo Compounds: p-Methoxyphenyl Ketone as a General Stereoselectivity Controlling Group.
J. Am. Chem. Soc. 2011, 133, 8972–8981. [CrossRef] [PubMed]
82. Goto, T.; Takada, K.; Anada, M.; Ando, K.; Hashimoto, S. Enantio- and diastereoselective cyclopropanation
with tert-butyl α-diazopropionate catalyzed by dirhodium(II) tetrakis[N-tetrabromophthaloyl-
(S)-tert-Leucinate]. Tetrahedron Lett. 2011, 52, 4200–4203. [CrossRef]
83. Goto, T.; Takada, K.; Shimada, N.; Nambu, H.; Anada, M.; Shiro, M.; Ando, K.; Hashimoto, S.
Highly enantioselective cyclopropenation reaction reaction of 1-Alkynes withα-alkyl-α-diazoesters catalyzed
by rhodium(II) carboxylates. Angew. Chem. Int. Ed. 2011, 50, 6803–6808. [CrossRef] [PubMed]
84. Xu, X.; Deng, Y.; Yim, D.N.; Zavalij, P.Y.; Doyle, M.P. Enantioselective cis-β-lactam synthesis by intramolecular
C-H functionalization from enoldiazoacetamides and derivative donor–acceptor cyclopropenes. Chem. Sci.
2015, 6, 2196–2201. [CrossRef] [PubMed]
85. Tsutsui, H.; Matsuura, M.; Makino, K.; Nakamura, S.; Nakajima, M.; Kitagaki, S.; Hashimoto, S.
Enantioselective Tandem Formation and [2,3]-Sigmatropic Rearrangement of Cyclic Propargylic Oxonium
Ylides Catalyzed by Dirhodium(II) Tetrakis[Naphthaloyl-(S)-tert-leucinate]. Isr. J. Chem. 2001, 41, 283–295.
[CrossRef]
86. Watanabe, N.; Ohtake, Y.; Hashimoto, S.; Shiro, M.; Ikegami, S. Asymmetric creation of quaternary carbon
centers by enantiotopically selective aromatic C-H insertion catalyzed by chiral dirhodium(II) carboxylates.
Tetrahedron Lett. 1995, 36, 1491–1494. [CrossRef]
87. DeAngelis, A.; Boruta, D.T.; Lubin, J.-B.; Plampin, J.N.; Yap, G.P.A.; Fox, J.M. The chiral crown conformation
in paddlewheel complexes. Chem. Commun. 2010, 46, 4541–4543. [CrossRef] [PubMed]
88. Nadeau, E.; Ventura, D.L.; Brekan, J.A.; Davies, H.M.L. Controlling factors for C-H functionalization versus
cyclopropanation of dihydronaphthalenes. J. Org. Chem. 2010, 75, 1927–1939. [CrossRef] [PubMed]
89. Adly, F.G.; Maddalena, J.; Ghanem, A. Rh2(S-1,2-NTTL)4: A Novel Rh2(S-PTTL)4 Analog With Lower
Ligand Symmetry for Asymmetric Synthesis of Chiral Cyclopropylphosphonates. Chirality 2014, 26, 764–774.
[CrossRef] [PubMed]
90. Kitagaki, S.; Anada, M.; Kataoka, O.; Matsuno, K.; Umeda, C.; Watanabe, N.; Hashimoto, S. Enantiocontrol in
Tandem Carbonyl Ylide Formation and Intermolecular 1,3-Dipolar Cycloaddition of α-Diazo Ketones
Mediated by Chiral Dirhodium(II) Carboxylate Catalyst. J. Am. Chem. Soc. 1999, 121, 1417–1418. [CrossRef]
91. Denton, J.R.; Sukumaran, D.; Davies, H.M.L. EnantioSelective Synthesis of trifluoromethyl-Substituted
Cyclopropanes. Org. Lett. 2007, 9, 2625–2628. [CrossRef] [PubMed]
92. Denton, J.R.; Cheng, K.; Davies, H.M.L. Stereoselective construction of nitrile-substituted cyclopropanes.
Chem. Commun. 2008, 1238–1240. [CrossRef] [PubMed]
Catalysts 2017, 7, 347 19 of 19
93. Denton, J.R.; Davies, H.M.L. Enantioselective reactions of donor/acceptor carbenoids derived from
α-aryl-α-diazoketones. Org. Lett. 2009, 11, 787–790. [CrossRef] [PubMed]
94. Chepiga, K.M.; Qin, C.; Alford, J.S.; Chennamadhavuni, S.; Gregg, T.M.; Olson, J.P.; Davies, H.M.L. Guide to
enantioselective dirhodium(II)-catalyzed cyclopropanation with aryldiazoacetates. Tetrahedron 2013, 69,
5765–5771. [CrossRef] [PubMed]
95. Briones, J.F.; Davies, H.M.L. Rh2(S-PTAD)4 catalyzed asymmetric cyclopropanation of aryl alkynes.
Tetrahedron 2011, 67, 4313–4317. [CrossRef]
96. Wang, H.; Guptill, D.M.; Varela-Alvarez, A.; Musaev, D.G.; Davies, H.M.L. Rhodium-catalyzed
enantioselective cyclopropanation of electron deficient alkenes. Chem. Sci. 2013, 4, 2844–2850. [CrossRef]
[PubMed]
97. Werlé, C.; Goddard, R.; Philipps, P.; Farès, C.; Fürstner, A. Stabilization of a Chiral Dirhodium Carbene
by Encapsulation and a Discussion of the Stereochemical Implications. Angew. Chem. Int. Ed. 2016, 55,
10760–10765. [CrossRef] [PubMed]
98. Adly, F.G.; Gardiner, M.G.; Ghanem, A. Design and Synthesis of Novel Chiral Dirhodium(II) Carboxylate
Complexes for Asymmetric Cyclopropanation Reactions. Chem.-Eur. J. 2016, 22, 3447–3461. [CrossRef]
[PubMed]
99. Mattiza, J.T.; Fohrer, J.G.G.; Duddeck, H.; Gardiner, M.G.; Ghanem, A. Optimizing dirhodium(II)
tetrakiscarboxylates as chiral NMR auxiliaries. Org. Biomol. Chem. 2011, 9, 6542–6550. [CrossRef] [PubMed]
100. Gardiner, M.G.; Ghanem, A. X-ray crystal structures of bis(EtOAc) and (MeOH)(H2O) adducts of
Rh2(S-PTPA)4 complex. Unpublished work, 2010.
101. Müller, P.; Ghanem, A. Rh(II)-Catalyzed Enantioselective Cyclopropanation of Olefins with Dimethyl
Malonate via in Situ Generated Phenyliodonium Ylide. Org. Lett. 2004, 6, 4347–4350. [CrossRef] [PubMed]
102. Ghanem, A.; Gardiner, M.G.; Williamson, R.M.; Müller, P. First X-ray Structure of a N-Naphthaloyl-Tethered
Chiral Dirhodium(II) Complex: Structural Basis for Tether Substitution Improving Asymmetric Control in
Olefin Cyclopropanation. Chem.-Eur. J. 2010, 16, 3291–3295. [CrossRef] [PubMed]
103. Adly, F.G.; Ghanem, A. Polymer monolith-supported dirhodium(II)-catalyzed continuous flow
cyclopropanation in capillary format. Tetrahedron Lett. 2016, 57, 852–857. [CrossRef]
104. Lindsay, V.N.G.; Charette, A.B. Design and Synthesis of Chiral Heteroleptic Rhodium(II) Carboxylate
Catalysts: Experimental Investigations of Halogen Bond Rigidification Effects in Asymmetric
Cyclopropanation. ACS Catal. 2012, 2, 1221–1225. [CrossRef]
105. Boruta, D.T.; Dmitrenko, O.; Yap, G.P.A.; Fox, J.M. Rh2(S-PTTL)3TPA—A mixed-ligand dirhodium(II) catalyst
for enantioselective reactions of α-alkyl-α-diazoesters. Chem. Sci. 2012, 3, 1589–1593. [CrossRef] [PubMed]
© 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
